• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconBiotech

Biotech

Page 16 of 19
Symbolic - biotechnology - genetic engineering
Tech
Guess What This Early Skype Investor Is Betting on Now
By ReutersFebruary 2, 2016
Key Speakers At The Stanford Institute For Economic Policy Research Forum
Leadership
Gilead CEO John Martin Is Stepping Down After 20 Years
By Jen WiecznerJanuary 29, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance
Biotech Stocks Crashed and Nobody Knows Why
By Jen WiecznerJanuary 28, 2016
Biosimilars Are Coming After Big Pharma’s Bottom Line
Health
Biosimilars Are Coming After Big Pharma’s Bottom Line
By Laura LorenzettiJanuary 12, 2016
AbbVie Inc. To Buy Shire For $54.8 Billion
Health
Shire-Baxalta $32 Billion Merger Talks Said to Advance
By Michal AddadyJanuary 3, 2016
Biotech’s Insane Year
Health
Biotech’s Insane Year
By Laura LorenzettiDecember 31, 2015
Inside of a Gilead Sciences Lab
Finance
Isis Pharmaceuticals Changes Its Name After Terrorists Attack Stock Price
By Jen WiecznerDecember 18, 2015
Packs of Wrigley chewing gum are displayed in Westerville, O
Tech
Doublemint Gum Is an Awesome Biosensor
By Hilary BrueckDecember 3, 2015
MSMB Capital Management CIO Martin Shkreli
Finance
Turing CEO Invested in This Penny Stock Biotech to Keep It Alive
By Laura LorenzettiNovember 19, 2015
CNBC Events - Clinton Global Initiative 2015
Tech
A Theranos Deal With Safeway Stores May be Falling Apart
By Daniel RobertsNovember 11, 2015
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Health
Astrazeneca is Buying ZS Pharma for $2.7 billion
By Laura LorenzettiNovember 6, 2015
MSMB Capital Management CIO Martin Shkreli
Health
This super-expensive drug is getting a $1 rival
By Benjamin SnyderOctober 23, 2015
Big pharma won’t stay silent in drug pricing debate for long
Health
Big pharma won’t stay silent in drug pricing debate for long
By Erika FryOctober 22, 2015
Biogen Idec Inc. CEO George Scangos Interview
Health
Profits up, Biogen cuts 11% of global workforce
By Erika FryOctober 21, 2015
Hillary Clinton in the first Democratic presidential debate in Las Vegas on Oct. 13
Commentary
Clinton’s big pharma takedown plan has some serious issues
By Chris Ford and Bethany CiancioloOctober 16, 2015
1...
  • 14
  • 15
  • 16
  • 17
  • 18
19
Most Popular
Success
Mark Cuban says he has the solution to growing income inequality, and it's to reward every employee—from CEO to janitor—with company stockplaceholder alt text
By Sasha RogelbergJuly 20, 2026
Success
‘I want to die broke’: Billionaire philanthropist Denny Sanford dies after giving away $4 billionplaceholder alt text
By Sydney LakeJuly 20, 2026
AI
'Dr. Doom' Nouriel Roubini says we're headed for universal basic income or 'some form of socialism' as AI revolutionizes work—He calls that optimisticplaceholder alt text
By Jason MaJuly 18, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.